(Q59617851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

p53 and related proteins in epithelial ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gordon C. Jayson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

K Reynolds

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

V Bajaj

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Swindell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Bromley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Ward

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P S Sengupta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A T McGown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J H Shanks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C H Buckley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R J Slade

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

2317-2328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Li-Fraumeni syndrome--a molecular and clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Quantification of p53 in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Double identity for proteins of the Bcl-2 family

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Expression and prognostic significance of Bcl-2 in ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

BAX protein expression and clinical outcome in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Cell kinetic studies in patients with small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Review: assessment of cell proliferation in histological material

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Flow cytometric evaluation of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900301-4

7 January 2021

10.1016/S0959-8049(00)00301-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11094305%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference